| Hürthle Cell Tumor of the Thyroid |
|
Woong Youn Chung;Suk Ju Kim;Cheong Soo Park |
| 갑상선의 Hürthle씨 세포 종양 |
|
정웅윤;김석주;박정수 |
|
|
|
|
| Abstract |
|
Hürthle cell neoplasm of the thyroid gland is an uncommon, but potentially malignant lesion. However, in many instances, the malignant potential of the Hürthle cell neoplasm is very difficult to judge histologically. For this reason, the biologic behavior of this tumor and its optimal treatment have come under considerable debate in recent years. In order to review the clinicopathologic features of the Hürthle cell neoplasm and to determine its optimal treatment modalities, we studied 26 patients with path logical proof of Hürthle cell tumor from January 1987 to September 1997. We also performed an immunohistochemical study using the monoclonal antibodies against antigen CD34 for the angiogenic activity of this tumor and evaluated the differences of microvessel density(MVD) between benign and malignant tumors.
The age of the patients ranged from 1 to 71 years with a mean of 44.2 years. There were 6 males and 20 females(M : F= 1 : 3.3). The accuracies of fine needle aspiration biopsy and frozen section were very low; 6.3% and 34.8%, respectively. There were 20 benign tumors and 6 malignant tumors(23.1%). All the malignant tumors were microinvasive(intermediate) type which had minimal capsular invasion and most of them(5 cases) were diagnosed postoperatively. Any specific clinicopathologic differences were not seen between benign and intermediate groups. Most of the cases had conservative surgeries(15 ipsilateral lobectomy-isthmusectomy, 7 subtotal thyroidectomy) while total thyroidectomy was performed in 4 cases. Of the cases with malignant tumor, 2 had ipsilateral lobectomy-isthmusectomy, 3 had subtotal thyroidectomy and the remaining 1 had total thyroidectomy.
Mean size of the tumors was 3.0 cm(0.1- 8.5 cm) in the greatest diameter and multiple tumors were seen in 6 cases(23.1 %). During the follow-up period, only one recurrence(3.8%) of benign tumor occurred but distant metastasis or cause-specific death was seen in the benign or intermediate groups.
Mean MVDs of the benign(n=13) and intermediate(n=6) groups were 121.7±35.3 and 114.3±31.7, respectively and there was no statistical significance between them.
In conclusion, because of the low accuracies of fine needle aspiration biopsy and frozen section for the Hürthle cell neoplasm, the extent of surgery could be individualized based on permanent pathologic examination; Conservative surgery would be adequate for patients with benign or intermediate Hürthle cell neoplasm and total or near-total thyroidectomy for those with definite malignancy. |
| Key Words:
Hürthle cell neoplasm, Thyroid gland, Tumor angiogenic activity |
|
PDF Links
Full text via DOI
Download Citation
